Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
AstraZeneca’s Once-Daily Oral GLP-1 Drug Elecoglipron Shows Strong Weight Loss and Diabetes Results, Moves Into Phase III Trials
A new oral drug from AstraZeneca is heading into large-scale clinical trials. Elecoglipron, a once-daily pill, mimics a natural gut hormone. Researchers are calling its early results clinically meaningful. The drug achieved over 11% average body weight loss in people…